Antibodies for Infectious Disease and Cancer
Pamlico BioPharma develops fully-human antibody therapeutics for infectious diseases. Our lead program is focused on antibodies to
Pamlico in the News
Pamlico BioPharma receives funding from Accele Venture Partners
Antibodies from Vaccine Antigens
Pamlico's technology can rapidly isolate and characterize antibodies produced by the human immune system in response to vaccine challenge.
Pamlico Biopharma Inc.
Copyright © 2018 All Rights Reserved